Education
About Us
Working with TipRanks
Follow Us
Astrazeneca Plc (AZN)
NASDAQ:AZN
AZN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$62.75 - $87.68
Previous CloseN/A
Volume1.80M
Average Volume (3M)5.52M
Market Cap
$229.16B
Enterprise Value$229.41B
Total Cash (Recent Filing)$5.49B
Total Debt (Recent Filing)$30.11B
Price to Earnings (P/E)32.5
Beta0.32
Next Earnings
Apr 29, 2025EPS Estimate
1.1Last Dividend Ex-Date
Feb 21, 2025Dividend Yield2.06%
Share Statistics
EPS (TTM)2.27
Shares Outstanding3,101,214,400
10 Day Avg. Volume4,420,707
30 Day Avg. Volume5,521,075
Financial Highlights & Ratios
PEG Ratio1.80
Price to Book (P/B)N/A
Price to Sales (P/S)4.31
Price to Cash Flow (P/CF)18.50
P/FCF Ratio25.00
Enterprise Value/Market Cap1.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.23
Enterprise Value/Ebitda13.32
Forecast
1Y Price Target
$93.18Price Target Upside26.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company reported product revenues of $13.362bn, beating consensus estimates of $13.050bn by ~2%.
Growth ProspectsAnalyst maintains an Outperform rating and target price due to strong fundamentals and growth prospects.
Product PipelineAZN has promising new products and pipeline, and participates in many large, high-growth markets.
Bears Say
China Business RisksCurrent investor concerns mainly revolve around risks to the China business due to alleged improper practices by former employees.
Roxadustat SalesDecreasing roxadustat China sales are expected in subsequent years due to expected VBP inclusion.
Tax And Legal IssuesAstraZeneca received notice regarding suspected unpaid importation taxes in China, presenting a potential financial risk.
---
Ownership Overview
―
Insiders
6.05% Mutual Funds
6.34% Other Institutional Investors
86.67% Public Companies and
Individual Investors
AZN FAQ
What was Astrazeneca Plc’s price range in the past 12 months?
Astrazeneca Plc lowest stock price was $62.75 and its highest was $87.67 in the past 12 months.
What is Astrazeneca Plc’s market cap?
Astrazeneca Plc’s market cap is $229.16B.
When is Astrazeneca Plc’s upcoming earnings report date?
Astrazeneca Plc’s upcoming earnings report date is Apr 29, 2025 which is in 30 days.
How were Astrazeneca Plc’s earnings last quarter?
Astrazeneca Plc released its earnings results on Feb 06, 2025. The company reported $1.045 earnings per share for the quarter, beating the consensus estimate of $1.035 by $0.01.
Is Astrazeneca Plc overvalued?
According to Wall Street analysts Astrazeneca Plc’s price is currently Undervalued.
Does Astrazeneca Plc pay dividends?
Astrazeneca Plc pays a Semiannually dividend of $1.519 which represents an annual dividend yield of 2.06%. See more information on Astrazeneca Plc dividends here
What is Astrazeneca Plc’s EPS estimate?
Astrazeneca Plc’s EPS estimate is 1.1.
How many shares outstanding does Astrazeneca Plc have?
Astrazeneca Plc has 3,101,214,400 shares outstanding.
What happened to Astrazeneca Plc’s price movement after its last earnings report?
Astrazeneca Plc reported an EPS of $1.045 in its last earnings report, beating expectations of $1.035. Following the earnings report the stock price went up 2.001%.
Which hedge fund is a major shareholder of Astrazeneca Plc?
Currently, no hedge funds are holding shares in AZN
---
AstraZeneca Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$93.18 (26.28% Upside)
$93.18 (26.28% Upside)
Blogger Sentiment
Bullish
AZN Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 1.0%
Last 30 Days ▲ 1.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.10%
12-Months-Change
Fundamentals
Return on Equity
17.60%
Trailing 12-Months
Asset Growth
2.88%
Trailing 12-Months
Company Description
Astrazeneca Plc
AstraZeneca (AZN) is a global biopharmaceutical company engaged in the discovery, development, and commercialization of prescription medicines. Operating in over 100 countries, AstraZeneca focuses on three main therapeutic areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. The company is committed to delivering life-changing medicines and has a robust pipeline of innovative therapies.
---
AZN Company Deck
---
AZN Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects strong overall performance with significant revenue growth, successful product approvals, and strategic pipeline advancements. However, challenges in the China market, anticipated headwinds from VBP and IRA, and increased operating expenses highlight areas of concern. The sentiment is balanced between strong growth prospects and operational challenges.Read More>---
AZN Stock 12 Month Forecast
Average Price Target
$93.18
▲(26.28% Upside)
Technical Analysis
Best Analysts Covering AZN
1 Year
1 Year Success Rate
25/33 ratings generated profit
1 Year Average Return
+8.80%
reiterated a buy rating last month
Copying Andrew Berens's trades and holding each position for 1 Year would result in 75.76% of your transactions generating a profit, with an average return of +8.80% per trade.
---